After recalls and infections, experts say safer eyedrops will require new FDA powers
By MATTHEW PERRONE AP Health Writer WASHINGTON (AP) — Repeated recalls of eyedrops are drawing new attention to the limited powers U.S. regulators…
Continue Reading